Groups

Dr. rer. nat. Hanns-Joachim Rziha:

Publications

______________________________________________________________________________________________________________________________________________________________________________________________________

Selected publications

 

Hanns-Joachim Rziha, Jörg Rohde, and Ralf Amann. Generation and Selection of Orf Virus (ORFV) Recombinants Methods Mol. Biol. 2016,  p. 177-200. doi: 10.1007/978-1-4939-3008-1_12.(book chapter)

Rohde J, Amann R, Rziha HJ. New Orf Virus (Parapoxvirus) Recombinant Expressing H5 Hemagglutinin Protects Mice against H5N1 and H1N1 Influenza A Virus. PLoS One. 20;8(12):e83802; 2013. 

Amann R, Rohde J, Wulle U, Conlee D, Raue R, Martinon O, Rziha HJ. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein. J Virol. 87(3):1618-30; 2013.

Rohde, J., Schirrmeier, H., Granzow, H. and H.-J. Rziha. A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV). Vaccine 29, 9256-9264; 2011.

van Rooij, E.M.A., Rijsewijk, F.A.M., Moonen-Leusen, H.W., Bianchi, A.T.J. and H.-J. Rziha. Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs. Vaccine 28, 1808-1813; 2010.

Grabowska, A.K., Lipinska, A.D., Rohde, J., Szewczyk, B, Bienkowska-Szewczyk, K. and H.-J. Rziha. New baculovirus recombinants expressing Pseudorabies virus (PRV) glycoproteins protect mice against lethal challenge infection. Vaccine 27, 3584-3591; 2009.

Dory, D., T. Fischer, V. Beven, R. Cariolet, H.-J. Rziha and A. Jestin. Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1). Vaccine 24, 6256-6263; 2006.

Hausmann, J., A. Pagenstecher, K. Baur, H.-J. Rziha and P. Staeheli. CD8 T cells require gamma interferon to clear Borna disease virus from the brain and prevent immune system-mediated neuronal damage. J. Virol. 79, 13509-13518; 2005.

Henkel, M., Planz, O., Fischer, T., Stitz, L. and H.-J. Rziha. Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant. J. Virol. 79, 314-325; 2005.

Fischer, T., O. Planz, L. Stitz and H.-J. Rziha. Novel recombinant Parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J. Virol. 77, 9312-9323; 2003.

Rziha, H.-J., M. Henkel, R. Cottone, B. Bauer, U. Auge, F. Götz, E. Pfaff, Röttgen, M., Dehio, C. and M. Büttner. Generation of recombinant parapoxviruses: Non-essential genes suitable for insertion and expression of foreign genes. J. Biotechnol., 83, 137-145; 2000.

Meyer, M., C. Lanz, M. Clauss, A. Lepple-Wienhaus, J. Waltenberger, H.G. Augustin, M. Ziche, M. Büttner, H.-J. Rziha and C. Dehio. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling by VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinase. EMBO J. 18, 363-374; 1999.